Nano-X Imaging Investors Face August Deadline in Securities Lawsuit

The lawsuit, spearheaded by the Rosen Law Firm, claims that Nano-X executives overstated operational gains while failing to disclose that production was poorly aligned with market demand. According to the complaint, these discrepancies led to ballooning operating expenses and a high cash burn rate, eventually forcing the company to undertake disruptive restructuring measures. Investors contend that these omissions rendered the company's public statements materially false and misleading.

Those who held NNOX stock during the specified class period may be eligible for compensation through a contingency fee arrangement, meaning no out-of-pocket costs are required to participate. While a lawsuit has been filed, no class has been certified yet. Investors retain the right to select their own counsel or remain absent class members, as the ability to share in any future recovery does not strictly depend on serving as a lead plaintiff.